- Ovid Therapeutics Inc To Host Research & Development (R&D) Day TranscriptOct 02, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Ovid Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Ovid Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Ovid Therapeutics Inc and Takeda Pharmaceutical Co Ltd to Discuss Strategic Transaction Call TranscriptMar 03, 2021
- Ovid Therapeutics Inc. - Special Call TranscriptOct 22, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptAug 25, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJul 13, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJun 17, 2020
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call TranscriptSep 23, 2019
- Ovid Therapeutics Inc. - Special Call TranscriptJun 27, 2019
Ovid Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning. I'm Jeremy Levin, Chairman of the Board of Directors and Chief Executive Officer of Ovid Therapeutics. And it's my great pleasure to welcome you to the company's 2021 Annual Meeting of Stockholders.
It's now 11 a.m., and I'll call this meeting to order and proceed with introductions and formal business of the annual meeting.
I'd like to start off by thanking everybody for joining us today. Please let me introduce to you the members of our senior management team present today: Dr. Amit Rakhit, President and CMO; Mr. Thomas Perone, General Counsel and Corporate Secretary; Mr. Jeff Rona, Chief Business and Financial Officer; Mr. Jason Tardio, Chief Commercial Officer. We're also pleased to introduce the other members of our Board of Directors who joined us today: Ms. Barbara Duncan and Mr. Bart Friedman.
I'd also like to introduce Thomas Klockner, Beth Raposo, Matt Interrante of KPMG LLP, our independent registered public accounting firm, who is available to respond to appropriate questions. And finally,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)